Vertex Pharmaceuticals (Europe) Limited
GPTKB entity
Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:ceo |
gptkb:Reshma_Kewalramani
|
| gptkbp:founded |
gptkb:1989
|
| gptkbp:headquarters |
Cambridge, Massachusetts, USA
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vertex Pharmaceuticals (Europe) Limited
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:location |
gptkb:Europe
|
| gptkbp:parent_company |
gptkb:Vertex_Pharmaceuticals_Incorporated
|
| gptkbp:products |
Cystic fibrosis drugs
|
| gptkbp:subsidiary |
gptkb:Vertex_Pharmaceuticals_Incorporated
|
| gptkbp:website |
www.vrtx.com
|
| gptkbp:bfsParent |
gptkb:Vertex_Pharmaceuticals
|
| gptkbp:bfsLayer |
4
|